@tomayates @Dr_J_Underwood @DrPJLillie @ElvyJuliet @docfok @Dhillon2Rishi @MGilchrist123 @ajosephnotts @ABsteward Also look out for the results of this trial, hopefully later this year: https://t.co/Qb6nLYPlmh
As the authors mention, the best option might be to use high doses of the less toxic flouroquinolone levofloxacin. For more studies on using higher doses of FQ for the treatment of TB https://t.co/MUoT1Rko9n https://t.co/DWph7kKYsR https://t.co/RZrELN33WE
An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial. https://t.co/zLnz9mdIdn https://t.co/RVrOTWlobk
Open Access UCL Research: An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial https://t.co/a8xTTOEJ4k